Revolutionizing Cancer Treatment.

Shivani Chopra is a senior scientist with expertise in functional genomics, assay development, and cell-based models, with experience leading projects in immunology and drug discovery. Prior to joining Reprogram Biosciences, she worked at GSK, where she applied functional genomic and phenotypic screening approaches to uncover and validate novel therapeutic targets. At Reprogram Biosciences, Shivani leads efforts to uncover how reprogramming factors reshape cell identity and function, applying her track record in target discovery to push the boundaries of what cell reprogramming can achieve therapeutically. She is passionate about translating innovative biology into meaningful therapies for patients.